(2002) Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ, 324, 71-86.
 Pignone, M., et al. (2010) Aspirin for primary prevention of cardiovascular events in people with diabetes: A position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation. Diabetes Care, 33, 1395-1402. http://dx.doi.org/10.2337/dc10-0555
 Eikelboom, J.W., et al., (2002) Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events. Circulation, 105, 1650-1655. http://dx.doi.org/10.1161/01.CIR.0000013777.21160.07
 Halushka, M.K. and Halushka, P.V. (2002) Why are some individuals resistant to the cardioprotective effects of aspirin? Could it be thromboxane A2? Circulation, 105, 1620-1622.
 Modica, A., Karlsson, F. and Mooe, T. (2007) Platelet aggregation and aspirin non-responsiveness increase when an acute coronary syndrome is complicated by an infection. Journal of Thrombosis and Haemostasis, 5, 507-511. http://dx.doi.org/10.1111/j.1538-7836.2007.02378.x
 Guthikonda, S., et al. (2007) Reticulated platelets and uninhibited COX-1 and COX-2 decrease the antiplatelet effects of aspirin. Journal of Thrombosis and Haemostasis, 5, 490-496.
 Zimmermann, N., et al. (2005) Is cardiopulmonary bypass a reason for aspirin resistance after coronary artery bypass grafting? European Journal Cardio-Thoracic Surgery, 27, 606-610.
 Zimmermann, N., et al. (2003) Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery. Circulation, 108, 542-547. http://dx.doi.org/10.1161/01.CIR. 0000081770.51929.5A
 Okada, S., et al. (2011) Differential effect of low-dose aspirin for primary prevention of atherosclerotic events in diabetes management: A subanalysis of the JPAD trial. Diabetes Care, 34, 1277-1283. http://dx.doi.org/10.2337/dc10-2451
 DiChiara, J., et al. (2007) The effect of aspirin dosing on platelet function in diabetic and nondiabetic patients: an analysis from the aspirin-induced platelet effect (ASPECT) study. Diabetes, 56, 3014-3019. http://dx.doi.org/10.2337/db07-0707
 De Berardis, G., et al. (2007) Aspirin and Simvastatin Combination for Cardiovascular Events Prevention Trial in Diabetes (ACCEPT-D): Design of a randomized study of the efficacy of low-dose aspirin in the prevention of cardiovascular events in subjects with diabetes mellitus treated with statins. Trials, 8, 21. http://dx.doi.org/10.1186/1745-6215-8-21
 Tirnaksiz, E., et al. (2009) Effect of high dose statin therapy on platelet function; statins reduce aspirin-resistant platelet aggregation in patients with coronary heart disease. Journal of Thrombosis and Haemostasis, 27, 24-28. http://dx.doi.org/10.1007/s11239-007-0154-1